pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Preclinical
    FID-023
    Leukemia Fulgent Pharma LLC
  • Preclinical
    FID-025
    Brain Cancer Fulgent Pharma LLC
  • Phase 2
    FKPC-101
    Metastatic Prostate Cancer CellVax Therapeutics Inc
  • Preclinical
← prev
page 19 of 62
next →
Pain89
Neurology1
FLAG-003
Pediatric Diffuse Intrinsic Pontine Glioma
Flag Therapeutics Inc
  • Preclinical
    FLAG-094
    Malignant Mesothelioma Flag Therapeutics Inc
  • Preclinical
    FMC-220
    Solid Tumor LG Chem Ltd
  • Phase 1
    FORX-428
    Metastatic Breast Cancer FoRx Therapeutics AG
  • Phase 1
    FPI-2068
    Metastatic Colorectal Cancer Fusion Pharmaceuticals Inc
  • Phase 2
    FPI-2265
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Fusion Pharmaceuticals Inc
  • Phase 1
    FS-120
    Advanced Malignancy invoX Pharma Ltd
  • Preclinical
    FT-002a-O
    Castration-Resistant Prostate Cancer (CRPC) AecorBio Inc
  • Phase 1
    FT-522
    B-Cell Non-Hodgkin Lymphoma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-576
    Refractory Multiple Myeloma$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-819
    Idiopathic Inflammatory Myopathy (IIM)$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-825
    Colorectal Cancer$FATE FATE THERAPEUTICS INC
  • Phase 1
    FT-836
    Breast Cancer$FATE FATE THERAPEUTICS INC
  • Preclinical
    FT-839
    Hematological Tumor$FATE FATE THERAPEUTICS INC
  • Preclinical
    FT-8XX
    Unspecified Cancer$FATE FATE THERAPEUTICS INC
  • Phase 2
    FWD-1802
    Metastatic Breast Cancer Shenzhen Forward Pharmaceutical Co Ltd
  • Phase 1
    G-207
    Anaplastic Astrocytoma Treovir LLC
  • Preclinical
    G2B-002
    Malignant Glioma Gate2Brain SL
  • Preclinical
    GADLEN Multiple-CD20
    Unspecified Cancer$STTK Shattuck Labs, Inc.
  • Preclinical
    GB-13
    Pediatric Diffuse Intrinsic Pontine Glioma Targepeutics Inc
  • Preclinical
    GB-264
    Gastrointestinal Tumor Genor BioPharma Co Ltd
  • Preclinical
    GB-266
    Unspecified Cancer Genor BioPharma Co Ltd
  • Preclinical
    GCC-2004
    B-Cell Non-Hodgkin Lymphoma$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GCC-4001
    Idiopathic Inflammatory Myopathy (IIM)$ARTV Artiva Biotherapeutics, Inc.
  • Phase 2
    GD2-SADA-177Lu-Proteus
    Melanoma Y-mAbs Therapeutics Inc
  • Preclinical
    GDT-002
    Pancreatic Ductal Adenocarcinoma Guidant Biotherapeutics Corp
  • Preclinical
    GEO-MVA-MUC1
    Breast Cancer$GOVX GeoVax Labs, Inc.